Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
J Clin Invest
    August 2022
  1. FOX DA
    Immunodeficiency and autoimmunity: companions not opposites.
    J Clin Invest. 2022;132.
    >> Share

    July 2022
  2. GRUDDA T, Hwang HS, Taddese M, Quinn J, et al
    Integrated hepatitis B virus DNA maintains surface antigen production during antivirals.
    J Clin Invest. 2022 Jul 7. pii: 161818. doi: 10.1172/JCI161818.
    >> Share

    June 2022
  3. TAKATA H, Trautmann L
    Transforming dysfunctional CD8+ T cells into natural controller-like CD8+ T cells: can TCF-1 be the magic wand?
    J Clin Invest. 2022;132.
    >> Share

    May 2022
  4. BALLE C, Armistead B, Kiravu A, Song X, et al
    Factors influencing maternal microchimerism throughout infancy and its impact on infant T cell immunity.
    J Clin Invest. 2022 May 12. pii: 148826. doi: 10.1172/JCI148826.
    >> Share

    April 2022
  5. FALCINELLI SD, Peterson JJ, Turner AW, Irlbeck D, et al
    Combined noncanonical NF-kappaB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo.
    J Clin Invest. 2022;132.
    >> Share

  6. PERDOMO-CELIS F, Passaes C, Monceaux V, Volant S, et al
    Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control.
    J Clin Invest. 2022 Apr 5. pii: 157549. doi: 10.1172/JCI157549.
    >> Share

  7. LEYRE L, Jones RB
    Hide and seek: for HIV-infected CD4+ T cells, playing well comes with maturity.
    J Clin Invest. 2022;132:1-4.
    >> Share

    March 2022
  8. VARCO-MERTH BD, Brantley W, Marenco A, Duell DD, et al
    Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapy.
    J Clin Invest. 2022 Mar 22. pii: 156063. doi: 10.1172/JCI156063.
    >> Share

  9. FERRARI B, Da Silva AC, Liu KH, Saidakova EV, et al
    Gut-derived bacterial toxins impair memory CD4 T-cell mitochondrialfunction in HIV-1infection.
    J Clin Invest. 2022 Mar 22. pii: 149571. doi: 10.1172/JCI149571.
    >> Share

  10. HARPER J, Ribeiro SP, Chan CN, Aid M, et al
    Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy.
    J Clin Invest. 2022 Mar 1. pii: 155251. doi: 10.1172/JCI155251.
    >> Share

    February 2022
  11. DUETTE G, Hiener B, Morgan H, Mazur FG, et al
    The HIV-1 proviral landscape reveals Nef contributes to HIV-1 persistence in effector memory CD4+ T-cells.
    J Clin Invest. 2022 Feb 8. pii: 154422. doi: 10.1172/JCI154422.
    >> Share

  12. ARMSTRONG E, Hemmerling A, Miller S, Burke KE, et al
    Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli.
    J Clin Invest. 2022 Feb 3. pii: 152930. doi: 10.1172/JCI152930.
    >> Share

    December 2021
  13. SHARAN R, Ganatra SR, Bucsan AN, Cole J, et al
    Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a tuberculosis/simian immunodeficiency virus coinfection model.
    J Clin Invest. 2021 Dec 2. pii: 153090. doi: 10.1172/JCI153090.
    >> Share

  14. CAMPION SL, Brenna E, Thomson E, Fischer W, et al
    Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial.
    J Clin Invest. 2021;131.
    >> Share

    November 2021
  15. SCULLY EP, Bryson BD
    Unlocking the complexity of HIV and Mycobacterium tuberculosis coinfection.
    J Clin Invest. 2021;131.
    >> Share

  16. MITCHELL JL, Pollara J, Dietze K, Edwards RW, et al
    Anti-HIV antibody development up to one year after antiretroviral therapy initiation in acute HIV infection.
    J Clin Invest. 2021 Nov 11. pii: 150937. doi: 10.1172/JCI150937.
    >> Share

    October 2021
  17. LI M, Garforth SJ, O'Connor KE, Su H, et al
    T-cell receptor-specific immunotherapeutics drive selective in vivo HIV and CMV-specific T-cell expansion in humanized mice.
    J Clin Invest. 2021 Oct 21. pii: 141051. doi: 10.1172/JCI141051.
    >> Share

    HIV-specific CAR T cells return to the clinic.
    J Clin Invest. 2021;131.
    >> Share

    September 2021
  19. QUINN TC
    Forty years of AIDS: a retrospective and the way forward.
    J Clin Invest. 2021;131.
    >> Share

  20. CORREA-MACEDO W, Fava VM, Orlova M, Cassart P, et al
    Alveolar macrophages from persons living with HIV show impaired epigenetic response to Mycobacterium tuberculosis.
    J Clin Invest. 2021 Sep 2. pii: e148013. doi: 10.1172/JCI148013.
    >> Share

  21. DIAS J, Fabozzi G, March K, Asokan M, et al
    Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging.
    J Clin Invest. 2021;131.
    >> Share

    August 2021
  22. LIU B, Zhang W, Xia B, Jing S, et al
    Broadly neutralizing antibody-derived CAR-T cells reduce viral reservoir in HIV-1-infected individuals.
    J Clin Invest. 2021 Aug 10. pii: e150211. doi: 10.1172/JCI150211.
    >> Share

  23. MENDEZ-LAGARES G, Chin N, Chang WLW, Lee J, et al
    Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function.
    J Clin Invest. 2021;131.
    >> Share

    July 2021
  24. BANSAL A, Gehre MN, Qin K, Sterrett S, et al
    HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection.
    J Clin Invest. 2021 Jul 6. pii: e148979. doi: 10.1172/JCI148979.
    >> Share

    June 2021
  25. ASTRONOMO RD, Lemos MP, Narpala SR, Czartoski J, et al
    Rectal and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge.
    J Clin Invest. 2021 Jun 24. pii: e146975. doi: 10.1172/JCI146975.
    >> Share

  26. REICHMANN MT, Tezera LB, Vallejo AF, Vukmirovic M, et al
    Integrated transcriptomic analysis of human tuberculosis granulomas and a biomimetic model identifies therapeutic targets.
    J Clin Invest. 2021 Jun 15. pii: e148136. doi: 10.1172/JCI148136.
    >> Share

  27. DUFOUR C, Gantner P, Fromentin R, Chomont N, et al
    The multifaceted nature of HIV latency.
    J Clin Invest. 2021;131.
    >> Share

  28. LI JZ, Blankson JN
    How elite controllers and posttreatment controllers inform our search for an HIV-1 cure.
    J Clin Invest. 2021;131.
    >> Share

    May 2021
  29. RIOU C, Du Bruyn E, Stek C, Daroowala R, et al
    Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and Tuberculosis co-infection.
    J Clin Invest. 2021 May 4. pii: 149125. doi: 10.1172/JCI149125.
    >> Share

  30. HARTANA CA, Rassadkina Y, Gao C, Martin-Gayo E, et al
    Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers.
    J Clin Invest. 2021;131.
    >> Share

    March 2021
  31. ZHANG C, Song JW, Huang HH, Fan X, et al
    NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients.
    J Clin Invest. 2021;131.
    >> Share

    February 2021
  32. OKOYE AA, Duell DD, Fukazawa Y, Varco-Merth B, et al
    CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.
    J Clin Invest. 2021 Feb 25. pii: 141677. doi: 10.1172/JCI141677.
    >> Share

  33. SAFER JD
    Research gaps in medical treatment of transgender/nonbinary people.
    J Clin Invest. 2021;131.
    >> Share

  34. TEBAS P, Jadlowsky JK, Shaw PA, Tian L, et al
    CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication.
    J Clin Invest. 2021 Feb 11. pii: 144486. doi: 10.1172/JCI144486.
    >> Share

  35. MATSUDA K, Migueles SA, Huang J, Bolkhovitinov L, et al
    A replication competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity.
    J Clin Invest. 2021 Feb 2. pii: 140794. doi: 10.1172/JCI140794.
    >> Share

    January 2021
  36. SWANSTROM AE, Immonen TT, Oswald K, Pyle C, et al
    Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapy.
    J Clin Invest. 2021 Jan 19. pii: 142421. doi: 10.1172/JCI142421.
    >> Share

    December 2020
  37. SIMONETTI FR, Zhang H, Soroosh GP, Duan J, et al
    Antigen-driven clonal selection shapes the persistence of HIV-1 infected CD4+ T cells in vivo.
    J Clin Invest. 2020 Dec 10. pii: 145254. doi: 10.1172/JCI145254.
    >> Share

  38. PILLAY BA, Fusaro M, Gray PE, Statham AL, et al
    Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency.
    J Clin Invest. 2020 Dec 8. pii: 142434. doi: 10.1172/JCI142434.
    >> Share

    October 2020
  39. HALVAS EK, Joseph KW, Brandt LD, Guo S, et al
    HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus.
    J Clin Invest. 2020 Oct 5. pii: 138099. doi: 10.1172/JCI138099.
    >> Share

  40. SILICIANO JD, Siliciano RF
    Nonsuppressible HIV-1 viremia: a reflection of how the reservoir persists.
    J Clin Invest. 2020 Oct 5. pii: 141497. doi: 10.1172/JCI141497.
    >> Share

  41. PEREZ-DIEZ A, Wong CS, Liu X, Mystakelis H, et al
    Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia.
    J Clin Invest. 2020;130:5326-5337.
    >> Share

    September 2020
  42. IGNATIUS EH, Cohen KA, Bishai WR
    Getting to the point in point-of-care diagnostics for tuberculosis.
    J Clin Invest. 2020 Sep 28. pii: 142497. doi: 10.1172/JCI142497.
    >> Share

  43. DUKE ER, Williamson BD, Borate B, Golob JL, et al
    Cytomegalovirus viral load kinetics as surrogate endpoints after allogeneic transplantation.
    J Clin Invest. 2020 Sep 24. pii: 133960. doi: 10.1172/JCI133960.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016